Literature DB >> 16299533

SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation.

Deepika Ahuja1, M Teresa Sáenz-Robles, James M Pipas.   

Abstract

DNA tumor viruses such as simian virus 40 (SV40) express dominant acting oncoproteins that exert their effects by associating with key cellular targets and altering the signaling pathways they govern. Thus, tumor viruses have proved to be invaluable aids in identifying proteins that participate in tumorigenesis, and in understanding the molecular basis for the transformed phenotype. The roles played by the SV40-encoded 708 amino-acid large T antigen (T antigen), and 174 amino acid small T antigen (t antigen), in transformation have been examined extensively. These studies have firmly established that large T antigen's inhibition of the p53 and Rb-family of tumor suppressors and small T antigen's action on the pp2A phosphatase, are important for SV40-induced transformation. It is not yet clear if the Rb, p53 and pp2A proteins are the only targets through which SV40 transforms cells, or whether additional targets await discovery. Finally, expression of SV40 oncoproteins in transgenic mice results in effects ranging from hyperplasia to invasive carcinoma accompanied by metastasis, depending on the tissue in which they are expressed. Thus, the consequences of SV40 action on these targets depend on the cell type being studied. The identification of additional cellular targets important for transformation, and understanding the molecular basis for the cell type-specific action of the viral T antigens are two important areas through which SV40 will continue to contribute to our understanding of cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299533     DOI: 10.1038/sj.onc.1209046

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  232 in total

Review 1.  Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.

Authors:  Shailender Bhatia; Olga Afanasiev; Paul Nghiem
Journal:  Curr Oncol Rep       Date:  2011-12       Impact factor: 5.075

Review 2.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

3.  Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.

Authors:  Patrick J Roberts; John E Bisi; Jay C Strum; Austin J Combest; David B Darr; Jerry E Usary; William C Zamboni; Kwok-Kin Wong; Charles M Perou; Norman E Sharpless
Journal:  J Natl Cancer Inst       Date:  2012-02-01       Impact factor: 13.506

4.  Identification of genes correlated with early-stage bladder cancer progression.

Authors:  Randolph Stone; Anita L Sabichi; Jennifer Gill; I-Ling Lee; Patrick Adegboyega; Michael S Dai; Raja Loganantharaj; Marjan Trutschl; Urska Cvek; John L Clifford
Journal:  Cancer Prev Res (Phila)       Date:  2010-05-25

5.  Conditional immortalization of primary adipocyte precursor cells.

Authors:  Christopher Church; Mallory Brown; Matthew S Rodeheffer
Journal:  Adipocyte       Date:  2015-01-20       Impact factor: 4.534

6.  Rad54 and Mus81 cooperation promotes DNA damage repair and restrains chromosome missegregation.

Authors:  S El Ghamrasni; R Cardoso; L Li; K K N Guturi; V A Bjerregaard; Y Liu; S Venkatesan; M P Hande; J T Henderson; O Sanchez; I D Hickson; A Hakem; R Hakem
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

7.  Single-chromosome Gains Commonly Function as Tumor Suppressors.

Authors:  Jason M Sheltzer; Julie H Ko; John M Replogle; Nicole C Habibe Burgos; Erica S Chung; Colleen M Meehl; Nicole M Sayles; Verena Passerini; Zuzana Storchova; Angelika Amon
Journal:  Cancer Cell       Date:  2017-01-12       Impact factor: 31.743

8.  Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.

Authors:  Haiping Zhou; Hong-ying Huang; Ellen Shapiro; Herbert Lepor; William C Huang; Moosa Mohammadi; Ian Mohr; Moon-shong Tang; Chuanshu Huang; Xue-ru Wu
Journal:  Carcinogenesis       Date:  2012-01-27       Impact factor: 4.944

9.  PP2A-dependent disruption of centrosome replication and cytoskeleton organization in Drosophila by SV40 small tumor antigen.

Authors:  S Kotadia; L R Kao; S A Comerford; R T Jones; R E Hammer; T L Megraw
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

10.  T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus.

Authors:  Masahiro Shuda; Huichen Feng; Hyun Jin Kwun; Steven T Rosen; Ole Gjoerup; Patrick S Moore; Yuan Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.